Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
MediaAlpha $144.2 million secondary offering
The Class A common stock is listed on the New York Stock Exchange
Ventas $500 million senior notes offering
We advised Ventas on its investment-grade debt offering
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
RxSight $115 million follow-on offering
The stock is listed on the Nasdaq Global Market
NatWest Group $1 billion contingent convertible Additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering
Oculis Holding $100 million at-the-market offering
The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
Meritage Homes $575 million convertible notes offering
The 1.75% convertible senior notes are due 2028
SS&C Technologies $750 million senior notes offering
We advised SS&C Technologies on the high-yield debt offering
ZEEKR Intelligent Technology $441 million IPO
We advised ZEEKR on its IPO and NYSE listing
Mastercard $1 billion senior notes offering
We advised Mastercard on its investment-grade debt offering